Response to reduced nicotine content cigarettes among smokers with chronic health conditions

Abstract

Individuals with chronic health conditions persist in smoking despite the presence of smoking-related illness. The aim of this study was to examine whether chronic health conditions moderate response to reduced nicotine content cigarettes (0.4, 2.4, 5.2, 15.8 mg/g of tobacco). This is a secondary analysis of a controlled clinical laboratory study that examined the acute effects of cigarettes varying in nicotine content among individuals especially vulnerable to smoking and tobacco dependence. Participants in the present study were categorized as having 0, 1–2, or ≥3 smoking-related chronic health conditions (i.e., chronic condition severity, CCS). Repeated-measures analysis of variance was used to examine whether CCS moderated response to cigarettes across measures of addiction potential (i.e., concurrent choice testing between nicotine dose pairs, Cigarette Purchase Task (CPT) performance, positive subjective effects), tobacco withdrawal, cigarette craving, and smoking topography. No main effects of CCS or interactions of CCS and nicotine dose were observed for concurrent choice testing, positive subjective effects, tobacco withdrawal, or smoking topography. Main effects of CCS were noted on the CPT with greater CCS being associated with less persistent demand. There was an interaction of CCS and nicotine dose on Factor 1 of the Questionnaire on Smoking Urges with the effects of dose significant only among those with 1–2 chronic conditions. Overall, we see minimal evidence that chronic condition severity affects response to reduced nicotine content cigarettes. A policy that reduces the nicotine content of cigarettes to minimally addictive levels may benefit smokers already experiencing smoking-related chronic conditions.

Effects of episodic future thinking on reinforcement pathology during smoking cessation treatment among individuals with substance use disorders

“…Consistent with the previous literature (see, e.g., Higgins et al 2018;Nighbor et al 2020;Smith et al 2017;Streck et al 2018;Weidberg et al 2018), the reduction in tobacco use resulted in a decrease in cigarette demand, specifically in O max and intensity of demand. Furthermore, this finding is congruent with others indicating that individuals with greater tobacco use show a higher cigarette demand (González-Roz et al 2019).…”

Tobacco smoking, related harm and motivation to quit smoking in people with schizophrenia spectrum disorders

“…Therefore, even though there is evidence that motivation to quit in smokers with schizophrenia spectrum disorders is quite similar to those of smokers without mental illness, it is evident that it is more difficult to help them to quit (Streck et al, 2018). Therefore, additional effective strategies of traditional cigarette smoking cessation, reduction and THR approach are needed.…”

Reduced nicotine in cigarettes in a marketplace with alternative nicotine systems: randomized clinical trial

“…A prior study showed that people who smoke with chronic health conditions experienced the same responses to reduced nicotine cigarettes as individuals without these conditions. 33 Third, we were not able to verify adherence to only smoking study cigarettes and in fact, participants reported using approximately one additional non-study cigarette per day throughout the VLNC vs. NNC condition. It is possible that a more profound effect of reducing nicotine in cigarettes might be observed if conventional nicotine cigarettes were unavailable.…”